Browse by author
Lookup NU author(s): Dr Diana Mansour
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Since its launch, more than 9 million women worldwide have used the levonorgestrel intra-uterine system (IUS) for contraception, as a treatment for heavy menstrual bleeding and as the progestogen component of hormone-replacement therapy. For women in their reproductive years, the IUS has become one of the most acceptable medical treatments for menorrhagia, reducing referrals to specialists and decreasing the need for operative gynaecological surgery. This article will outline the development of the IUS, highlighting the most important recent areas of research covering its use to control menstrual blood loss and pain.
Author(s): Mansour D
Publication type: Article
Publication status: Published
Journal: Best Practice & Research: Clinical Obstetrics & Gynaecology
ISSN (electronic): 1532-1932
Publisher: Bailliere Tindall
Altmetrics provided by Altmetric